Skip to main navigation

Fate Therapeutics

0
Skip to content
  • About Us
    • Our Mission
    • Our Cells of Interest
    • Management
    • Board of Directors
    • Corporate Responsibility
  • Pipeline
    • Overview
    • Product Candidates
      • FT576
      • FT522
      • FT819
      • FT825
    • Expanded Access Policy
  • Science
    • iPSC Platform
    • Manufacturing
    • Publications
  • Collaborations
  • Working at Fate
    • The Fate Way
    • Join our Team
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historic Stock Lookup
    • Investors FAQs
  • Contact
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financial & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
    • Investors FAQs

Annual Reports and Proxies

Annual Reports

Title View
2022 Annual Report 2.3 MB
2022 Annual Report 2.3 MB
2021 Annual Report 2.1 MB
2021 Annual Report 2.1 MB
2020 Annual Report 1.1 MB
2020 Annual Report 1.1 MB
2019 Annual Report 1.1 MB
2019 Annual Report 1.1 MB
2018 Annual Report 9.6 MB
2018 Annual Report 9.6 MB
2017 Annual Report 4 MB
2017 Annual Report 4 MB
2016 Annual Report 4.7 MB
2016 Annual Report 4.7 MB
2015 Annual Report 998.1 KB
2015 Annual Report 998.1 KB
2014 Annual Report 7 MB
2014 Annual Report 7 MB

Financials & Filings submenus

  • SEC Filings
  • Annual Reports and Proxies

Proxy Statements

Filing date View
Apr 21, 2023 View HTML
0001193125-23-110475.pdf
0001193125-23-110475.xls
Apr 25, 2022 View HTML
0001193125-22-117516.pdf
0001193125-22-117516.xls
Apr 21, 2021 View HTML
0001193125-21-124699.pdf
0001193125-21-124699.xls
Mar 20, 2020 View HTML
0001193125-20-080623.pdf
0001193125-20-080623.xls

Shareholder Tools

Printed Materials
Email Alerts
Download Library
RSS News Feeds
Print Page
Share
Search

  • Facebook
  • LinkedIn
  • Twitter
  • RSS

© 2023 Fate Therapeutics | 3535 General Atomics Court, Suite 200, San Diego 92121 | 866.875.1833 | LEGAL

MENU
  • About Us
    • Our Mission
    • Our Cells of Interest
    • Management
    • Board of Directors
    • Corporate Responsibility
  • Pipeline
    • Overview
    • Immuno-Oncology Candidates
      • FT576
      • FT819
    • Expanded Access Policy
  • Science
    • iPSC Platform
    • Manufacturing
    • Publications
  • Collaborations
  • Working at Fate
    • The Fate Way
    • Join our Team
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
      • Annual Reports and Proxies
    • Corporate Governance
    • Stock Information
      • Historic Stock Lookup
    • Investors FAQs
  • Contact